Recently, Bayat et al. proposed that pre-inhibited carbonic anhydrases significantly potentiate the reduction of NB tumorigenesis by the HDAC inhibitor MS-275, indicating that CA9 inhibitor could be a promising therapeutic approach for NB patients [47]. The gene discussed is CA9; the disease is neuroblastoma.